Published by Reuters UKBy Maggie Fick LONDON (Reuters) - British drugmaker GSK's HIV treatment division, ViiV Healthcare, published data on Wednesday … [Read more...] about GSK’s ViiV says study shows its long-acting HIV shot as effective as Gilead’s daily pill